cyc 202 has been researched along with sl0101 in 1 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (sl0101) | Trials (sl0101) | Recent Studies (post-2010) (sl0101) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 30 | 0 | 19 |
| Protein | Taxonomy | cyc 202 (IC50) | sl0101 (IC50) |
|---|---|---|---|
| Ribosomal protein S6 kinase alpha-3 | Homo sapiens (human) | 0.4242 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alessi, DR; Arthur, JS; Bain, J; Cohen, P; Elliott, M; Hastie, CJ; Klevernic, I; McLauchlan, H; Plater, L; Shpiro, N | 1 |
1 other study(ies) available for cyc 202 and sl0101
| Article | Year |
|---|---|
The selectivity of protein kinase inhibitors: a further update.
Topics: Amino Acid Sequence; Animals; Cell Line; Drug Design; Enzyme Activation; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Recombinant Proteins; Spodoptera | 2007 |